logo

For the Inventor, By the Inventor

Tokyo, Japan

Akiko Ando

This inventor holds 8 USPTO granted patents. Top assignee: Sankyo Company, Limited. Active years: 1977-1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akiko Ando. Retrieved from https://idiyas.com/inventor/akiko-ando

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 53(Granted Patents)


Location History:

  • Tokyo, JA (1977 - 1978)
  • Hiromachi, JP (1981 - 1988)

Company Filing History:

goldMedal8 out of 613 
 
Sankyo Company, Limited
 patents

Years Active: 1977-1988

Loading Chart...
8 patents (USPTO):Explore Patents
1. 4778790 - Perhydrothiazepine and perhydroazepine derivatives and their therapeutic (1988-10-18),
2. 4734410 - Lactam derivatives and their use as hypotensive agents (1988-03-29),
3. 4699905 - Perhydrothiazepine derivatives, their preparation and their therapeutic (1987-10-13),
4. 4247548 - 7.alpha.-Methoxycephalosporin derivatives and their pharmaceutical (1981-01-27),
5. 4071681 - Process for preparing beta-lactam antibiotic substances (1978-01-31),
6. 4051320 - Process for preparing alkoxylated derivatives of cephalosporin compounds (1977-09-27),
7. 4048155 - Process for preparing 7 .alpha.-alkoxycephalosporin derivatives (1977-09-13),
8. 4016155 - Process for preparing cephalosporin derivatives (1977-04-05),

Title: Akiko Ando: Innovator in Hypotensive Agents

Introduction

Akiko Ando is a prominent inventor based in Tokyo, Japan. She has made significant contributions to the field of pharmaceuticals, particularly in the development of hypotensive agents. With a total of 8 patents to her name, Ando's work has had a considerable impact on medical science.

Latest Patents

Among her latest patents are innovative compounds such as perhydrothiazepine and perhydroazepine derivatives. These compounds are valuable hypotensive agents that can be synthesized through a condensation reaction involving specific amino group compounds. Another notable patent includes lactam derivatives, which also serve as hypotensive agents, showcasing her expertise in creating effective therapeutic solutions.

Career Highlights

Ando is currently employed at Sankyo Company, Limited, where she continues to advance her research and development efforts. Her work has been instrumental in creating new medications that address hypertension, a critical health issue worldwide.

Collaborations

Throughout her career, Ando has collaborated with esteemed colleagues such as Hiroaki Yanagisawa and Hideo Nakao. These partnerships have fostered a collaborative environment that enhances innovation and the development of new therapeutic agents.

Conclusion

Akiko Ando's contributions to the field of hypotensive agents exemplify her dedication to medical innovation. Her patents and collaborative efforts continue to pave the way for advancements in pharmaceutical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…